Amniochorionic Membrane Cells in the Maternal Blood as a Biomarker for Preterm Birth
Condition(s):Preterm Birth; Preterm Premature Rupture of Membrane; Preterm LaborLast Updated:January 12, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Preterm Birth; Preterm Premature Rupture of Membrane; Preterm LaborLast Updated:January 12, 2021Not yet recruiting
Condition(s):Pathology of PregnancyLast Updated:December 4, 2014Unknown status
Condition(s):Fetal Growth Restriction; Antiphospholipid SyndromeLast Updated:January 5, 2015Unknown status
Condition(s):Fetal Alcohol Spectrum Disorders; Fetal Alcohol SyndromeLast Updated:October 1, 2020Not yet recruiting
Condition(s):Body Composition; ObesityLast Updated:June 24, 2020Completed
Condition(s):PreeclampsiaLast Updated:January 24, 2014Unknown status
Condition(s):Hepatitis C; Infection Transmission, Maternal-FetalLast Updated:April 9, 2018Completed
Condition(s):Preterm Labor (24 GA – 32 GA)Last Updated:June 18, 2018Completed
Condition(s):Preterm Premature Rupture of Fetal MembranesLast Updated:November 29, 2016Unknown status
Condition(s):Preterm Premature Rupture of MembraneLast Updated:October 11, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.